Cargando…
Field evaluation of GeneXpert(®) (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in Cambodia
GeneXpert(®) (Cepheid) is the only WHO prequalified platform for hepatitis C virus (HCV) nucleic acid amplification testing that is suitable for point‐of‐care use in resource‐limited contexts. However, its application is constrained by the lack of evidence on genotype 6 (GT6) HCV. We evaluated its f...
Autores principales: | Iwamoto, Momoko, Calzia, Aurelie, Dublineau, Amelie, Rouet, François, Nouhin, Janin, Yann, Sokchea, Pin, Sophorn, Sun, Chhorvy, Sann, Kimchamroeun, Dimanche, Chhit, Lastrucci, Celine, Coulborn, Rebecca M., Maman, David, Dousset, Jean‐Philippe, Loarec, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379744/ https://www.ncbi.nlm.nih.gov/pubmed/30199587 http://dx.doi.org/10.1111/jvh.13002 |
Ejemplares similares
-
Recommendations for sample pooling on the Cepheid GeneXpert(®) system using the Cepheid Xpert(®) Xpress SARS-CoV-2 assay
por: Becker, Michael G., et al.
Publicado: (2020) -
Field evaluation of near point of care Cepheid GeneXpert HIV-1 Qual for early infant diagnosis
por: Opollo, Valarie Sarah, et al.
Publicado: (2018) -
Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus
por: Pinsky, Benjamin A., et al.
Publicado: (2015) -
Performance comparison of the cobas Liat and Cepheid GeneXpert systems for Clostridium difficile detection
por: Granato, Paul A., et al.
Publicado: (2018) -
Performance and usability of Cepheid GeneXpert HIV-1 qualitative and quantitative assay in Kenya
por: Bwana, Priska, et al.
Publicado: (2019)